The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Dec. 01, 2017
Applicant:

Abbvie Inc., North Chicago, IL (US);

Inventors:

Eric C. Breinlinger, Charlton, MA (US);

Phil B. Cox, Grayslake, IL (US);

Justin D. Dietrich, Lindenhurst, IL (US);

Kristine E. Frank, Grayslake, IL (US);

Michael M. Friedman, Brookline, MA (US);

Huan-Qui Li, Wilmette, IL (US);

Kenton L. Longenecker, Grayslake, IL (US);

Augustine T. Osuma, Lindenhurst, IL (US);

Ann Marie Rowley, Libertyville, IL (US);

Anil Vasudevan, Lake Forest, IL (US);

Noel S. Wilson, Kenosha, WI (US);

Jerome Daanen, Racine, WI (US);

Stevan Djuric, Lake Bluff, IL (US);

Amanda W. Dombrowski, Chicago, IL (US);

Arthur Gomtsyan, Vernon Hills, IL (US);

Robert Schmidt, Antioch, IL (US);

Assignee:

AbbVie Inc., North Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 521/00 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); C07D 498/14 (2006.01); C07D 498/18 (2006.01); C07D 498/20 (2006.01); C07D 498/22 (2006.01); C07D 519/00 (2006.01); C07D 471/18 (2006.01); C07D 491/147 (2006.01); C07D 491/22 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 471/18 (2013.01); C07D 487/04 (2013.01); C07D 491/147 (2013.01); C07D 491/22 (2013.01); C07D 498/04 (2013.01); C07D 498/14 (2013.01); C07D 498/18 (2013.01); C07D 498/20 (2013.01); C07D 498/22 (2013.01); C07D 519/00 (2013.01);
Abstract

The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.


Find Patent Forward Citations

Loading…